Overview

Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Amantadine will provide a safe yet synergistic effect that induces or accelerates functional recovery.
Phase:
N/A
Details
Lead Sponsor:
Edward Hines Jr. VA Hospital
Treatments:
Amantadine